BiotechTube
Home/PharmaEssentia/Ko-Chung Lin
KL

Ko-Chung Lin

Founder and CEO

PharmaEssentia

Therapeutic Areas

Hematologic OncologyOncology

PharmaEssentia Pipeline

DrugIndicationPhase
Ropeginterferon alfa-2b (BESREMi®)Polycythemia Vera (PV)Approved
Ropeginterferon alfa-2bEssential Thrombocythemia (ET)Phase III
KX01 (Tirbanibulin)Gastric/Gastro-esophageal/Esophageal CancersPhase I

Leadership Team at PharmaEssentia

CT
Ching-Leou Teng
Chairperson
C(
Cheng-Ku (Jack) Hwang
General Manager, HQ
LL
Lih-Ling Lin
Chief Scientific Officer
AQ
Albert Qin
Chief Medical Officer
KY
Katsuya Yonezu
Representative Director & General Manager of Japan Operations
View full PharmaEssentia profile